Optiver Holding
GILD icon

Optiver Holding’s Gilead Sciences GILD Stock Holding History

Optiver Holding’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Buy
+1,941
New +$256K ﹤0.01% 856
2024
Q4 		– Sell
-7,168
Closed -$601K – 1096
2024
Q3 		$601K Buy
+7,168
New +$547K ﹤0.01% 395
2024
Q1 		– Sell
-25
Closed -$2.02K – 705
2023
Q4 		$2.02K Buy
25
+20
+400% +$1.56K ﹤0.01% 473
2023
Q3 		$375 Buy
+5
New +$385 ﹤0.01% 541
2022
Q2 		– Sell
-68
Closed -$4K – 419
2022
Q1 		$4K Sell
68
-134
-66% -$8.57K ﹤0.01% 475
2021
Q4 		$14K Buy
202
+47
+30% +$3.24K ﹤0.01% 651
2021
Q3 		$11K Sell
155
-187
-55% -$13.1K ﹤0.01% 560
2021
Q2 		$24K Buy
+342
New +$22.8K ﹤0.01% 347

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Optiver Holding's GILD Position: Q2 2026 in Review

Optiver Holding opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,941 shares worth $245K. The stake represents ﹤0.01% of the portfolio and ranks #856 among its holdings. This is a return to the name: Optiver Holding previously reported a position in GILD as recently as Q3 2024.

Optiver Holding first reported a position in GILD in Q2 2021 and has held it in 8 quarters since. The position peaked at $601K in Q3 2024. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Optiver Holding held 1,941 shares of Gilead Sciences worth $245K as of Q2 2026.
  • Gilead Sciences was a new Optiver Holding position in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #856 holding.
  • Optiver Holding first reported a position in Gilead Sciences in Q2 2021 and has held it in 8 quarters since.
  • Optiver Holding's Gilead Sciences position peaked at $601K in Q3 2024.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.